Skip Navigation Links

Solvay | Strategy and Financial Highlights Information from ICIS

 

Edited from “strategy”, company website

 

The “change strategy” that was first launched in 1998 focused on two major elements: strengthening the company’s leadership in all of its activities and accelerating the development of the pharmaceuticals sector and its specialties products. These objectives are said to have been met and the company will now strategically focus in 2008 on the following three areas: growth in pharmaceuticals, chemicals and selected plastic areas; innovation; and increasing its presence in Asia, the Americas and Eastern EuropeBust of Ernest Solvay (Source: Raphael Cardinael/Rex Features)

 

“The strategy we have chosen is clear, such a strategy is possible only within a long-term vision”, says chairman, Christian Jourquin.

 

Its strategy of leadership and faster development in pharmaceuticals and specialities, and of geographic deployment in high-growth zones, is expected to be of a ‘winning combination’. In addition, the company is benefiting from the results of a group-wide innovation initiative, which is bringing new product, processes and applications, as well as improvements at all levels across the company.

 

Solvay further says that it is aiming for more than €1.1bn ($1.54bn) in additional sales by 2012 from new projects in chemicals and plastics as well as pharmaceuticals growth. The company is planning to grow in emerging markets such as Egypt, the Mercosur countries, Russia and Thailand as well as reduce cyclicality in the business.

 

It further expects 20% of its pharmaceutical sales to come from emerging markets.

Due to decreasing availability of fossil energy, leading to higher prices and volatility, a technology push and regulatory pull is making renewable energies increasingly attractive.

 

“Energy has become a crucial competitive differentiator, and fundamental changes are to be expected in the whole industry”, says Jourquin.

 

The risk of supply shortages and less predictable profitability has led Solvay to invest in bioethanol projects in Brazil, as well as to focus on vertical integration in chemicals and plastics.

 

Pharmaceuticals strategy for 2010

 

  1. Concentrate on therapeutic fields.
  2. Improve profitability with an operating margin of 20%.
  3. Annual savings of €300m.
  4. Sales in excess of 20% to €3.2bn.
  5. Increase R&D/sales ratio.

 

Chemicals strategy for 2010

 

  1. To follow a policy of continuous improvement.
  2. Manage its product portfolio.
  3. Growth in specialties (mainly bicarbonate and fluorinated and organic specialties).
  4. To open up new paths, especially in organic chemistry, with strong external support from partnering relationships with major customers and internal support from its innovation drive.
  5. Continuing geographic expansion through investments in flagship products and in high-growth areas.
  6. Pursue technological innovation.

 

Plastics strategy for 2010 (for the two activity clusters, specialties and vinyls)

 

  1. To capitalise on existing strengths, size and global presence, technological leadership, and potential for synergy.
  2. Management of the activities portfolio in terms of added value, growth potential and resistance to business cycles.
  3. Constant strengthening of competitiveness, R&D and customer proximity.
  4. Restructurings, modernisations, expansions and acquisitions.
  5. Strict control of strategic initiatives and operations.
  6. Constant search for new business opportunities.

 

Please also see Solvay may reinvest in Asia after pharma sale – PwC on ICIS news.

 


Download the The ICIS Top 100 Chemical Companies listing here

 

Financial highlights: Solvay, year ended 31 December

 

 

2010

 2009

 2008

 2007

 2006

Sales (€ m)

7,109

8,485

9,490

9,572

9,399

Operating Profit (€ m)

305

864

965

1,192

1,099

Net Profit (€ m)

1,823

553

449

828

817

Total Assets (€ m)

14,014

12,546

12,264

11,180

5,944

Diluted earnings per share (€)

21.85

6.28

4.92

 9.46

9.57

Number of Employees

16,800

28,204

29,443

28,340

29,258

 

Currency Converter by OANDA.com, The Currency Site.

Solvay Company Structure

Solvay operates in pharmaceuticals, chemicals and plastics. In 1861, Ernest Solvay developed a revolutionary ammonia-soda process for producing sodium carbonate. The Solvay group was founded in 1863 to exploit this process.
More about Solvay Structure

News:

Get news on Solvay plus the latest chemical news, information, data, market movements and analysis in one place with ICIS news

Search:

Find details on other chemical companies and suppliers with ICIS search

Newsletters:

ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.

Plants and projects:

Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database

 
Free trial to ICIS
Malini Hariharan - India Chemicals Blog
India is proving a hot spot for chemicals growth. Malini Hariharan comments on developments in her India Chemicals Blog here.

Insight

INSIGHT: The prize will go to first movers in US olefins build-out
"The prize will be to tap into the peak, or at least the near peak, of the ethylene/petrochemical cycle." more

VIDEO: ICIS Special Report - Asia methanol, acetic acid

More...

We welcome your feedback. Please feel free to send us your comments on any aspect of this site. Click here to make your comments.